Barrier Therapeutics, Inc., a pharmaceutical company developing products in the field of dermatology, reported positive phase 2a data for both oral Rambazole in the treatment of psoriasis, and for ...
Barrier Therapeutics Announces Azoline Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints PRINCETON, NJ -- Mar 27, 2007 -- Barrier Therapeutics, Inc., a pharmaceutical ...
28 x 23 in. (71.1 x 58.4 cm.) Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results